Co-Diagnostics Inc (CODX)

[Opti Mist]

Theodore O'Neill

Thank you so much. The question I have is on the strategy for the PCR Home test. Wouldn't it make more sense to market this to doctors' offices and veterinarians first and then have it sort of become the gold standard and then bring it to the masses? And I was wondering if you could talk about why you've chosen to market to the masses first.

Dwight Egan

Yes. So Theo - nice to hear from, Theo. This was also part of the question that was asked by the analyst from H.C. Wainwright. We are marketing to both the at-home market and the physician office and the dental market and secondarily to that, to the veterinary market and chiropractic market and such.

We have spent a considerable amount of money on market - field market researching with Radius, which is a very good company in field marketing research, one of the best in the world. And so they've done a significant study for us as to how our product would be received and at what price points and such.

And you are quite right. The physician and dentistry markets are primary for the introduction of this test on a point of care basis. We refer to the product as it relates to physicians and dentists as - as the Co-Dx PCR Pro device, but it is basically the same device.

And I think the takeaway I would want you to get from this, Theo, is that we've taken more time than we had originally expected to bring this device to get ready for the clinical trials. And at the end of the day, we ended up with a much more robust device than we had previously set out to do.

And so we're very comfortable taking it into the physicians and dentists and into those markets that indeed are really a great market to take this, and we - that's what we will be doing. We'll be doing that concurrently with what we're taking into the home market. It's going to involve more than just the home market, right from the get-go.